Literature DB >> 6160848

Altered purine and pyrimidine metabolism in erythrocytes with purine nucleoside phosphorylase deficiency.

I H Fox, J Kaminska, N L Edwards, E Gelfand, K C Rich, W N Arnold.   

Abstract

Purine and pyrimidine metabolism was compared in erythrocytes from three patients from two families with purine nucleoside phosphorylase deficiency and T-cell immunodeficiency, one heterozygote subject for this enzyme deficiency, one patient with a complete deficiency of hypoxanthine-guanine phosphoribosyltransferase, and two normal subjects. The erythrocytes from the heterozygote subject were indistinguishable from the normal erythrocytes. The purine nucleoside phosphorylase deficient erythrocytes had a block in the conversion of inosine to hypoxanthine. The erythrocytes with 0.07% of normal purine nucleoside phosphorylase activity resembled erythrocytes with hypoxanthine-guanine phosphoribosyltransferase deficiency by having an elevated intracellular concentration of PP-ribose-P, increased synthesis of PP-ribose-P, and an elevated rate of carbon dioxide release from orotic acid during its conversion to UMP. Two hypotheses to account for the associated immunodeficiency--that the enzyme deficiency leads to a block of PP-ribose-P synthesis or inhibition of pyrimidine synthesis--could not be supported by observations in erythrocytes from both enzyme-deficient families.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6160848     DOI: 10.1007/BF00484238

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  45 in total

1.  Partial deficiency of purine nucleoside phosphorylase: studies of purine and pyrimidine metabolism.

Authors:  N L Edwards; E W Gelfand; D Biggar; I H Fox
Journal:  J Lab Clin Med       Date:  1978-05

2.  A specific enzyme defect in gout associated with overproduction of uric acid.

Authors:  W N Kelley; F M Rosenbloom; J F Henderson; J E Seegmiller
Journal:  Proc Natl Acad Sci U S A       Date:  1967-06       Impact factor: 11.205

3.  Biochemical bases of accelerated purine biosynthesis de novo in human fibroblasts lacking hypoxanthine-guanine phosphoribosyltransferase.

Authors:  F M Rosenbloom; J F Henderson; I C Caldwell; W N Kelley; J E Seegmiller
Journal:  J Biol Chem       Date:  1968-03-25       Impact factor: 5.157

4.  A second case of inosine phosphorylase deficiency with severe T-cell abnormalities.

Authors:  M Hamet; C Griscelli; P Cartier; J Ballay; C de Bruyn; P Hösli
Journal:  Adv Exp Med Biol       Date:  1977       Impact factor: 2.622

5.  Identification and quantitation of adenine deoxynucleotides in erythrocytes of a patient with adenosine deaminase deficiency and severe combined immunodeficiency.

Authors:  M S Coleman; J Donofrio; J J Hutton; L Hahn; A Daoud; B Lampkin; J Dyminski
Journal:  J Biol Chem       Date:  1978-03-10       Impact factor: 5.157

6.  Inherited disorder of purine metabolism. Correlation between central nervous system dysfunction and biochemical defects.

Authors:  F M Rosenbloom; W N Kelley; J Miller; J F Henderson; J E Seegmiller
Journal:  JAMA       Date:  1967-10-16       Impact factor: 56.272

7.  Cellular immune deficiency with autoimmune hemolytic anemia in purine nucleoside phosphorylase deficiency.

Authors:  K C Rich; W J Arnold; T Palella; I H Fox
Journal:  Am J Med       Date:  1979-07       Impact factor: 4.965

8.  Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase.

Authors:  A Cohen; D Doyle; D W Martin; A J Ammann
Journal:  N Engl J Med       Date:  1976-12-23       Impact factor: 91.245

9.  Inhibition of phosphoribosylpyrophosphate synthesis by purine nucleosides in human erythrocytes.

Authors:  G Planet; I H Fox
Journal:  J Biol Chem       Date:  1976-10-10       Impact factor: 5.157

10.  Pyrimidine starvation induced by adenosine in fibroblasts and lymphoid cells: role of adenosine deaminase.

Authors:  H Green; T Chan
Journal:  Science       Date:  1973-11-23       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.